Kevin Caliendo
Stock Analyst at UBS
(4.18)
# 425
Out of 5,241 analysts
217
Total ratings
63.3%
Success rate
9.74%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACH Accendra Health | Maintains: Neutral | $3 → $4.5 | $2.91 | +54.64% | 1 | May 12, 2026 | |
| MCK McKesson | Maintains: Buy | $1,000 → $1,050 | $760.57 | +38.05% | 19 | May 8, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $18 → $17 | $10.07 | +68.82% | 14 | May 7, 2026 | |
| COR Cencora | Maintains: Buy | $410 → $412 | $257.71 | +59.87% | 5 | May 7, 2026 | |
| CVS CVS Health | Maintains: Buy | $97 → $100 | $95.89 | +4.29% | 12 | May 7, 2026 | |
| SOLV Solventum | Maintains: Neutral | $82 → $78 | $74.26 | +5.04% | 3 | May 6, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $87 → $85 | $72.72 | +16.89% | 8 | May 6, 2026 | |
| AHCO AdaptHealth | Maintains: Buy | $15 → $14 | $10.66 | +31.33% | 1 | May 6, 2026 | |
| DGX Quest Diagnostics | Maintains: Neutral | $210 → $220 | $186.61 | +17.89% | 18 | Apr 22, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $3.96 | +26.26% | 4 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $57 | $36.19 | +57.50% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $7.65 | +56.86% | 7 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $185 | $157.25 | +17.65% | 20 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $25 | $23.22 | +7.67% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $21 | $15.73 | +33.50% | 9 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.43 | +64.61% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $195.20 | +12.70% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $393.85 | +9.18% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $250.40 | +27.80% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $184.99 | -8.10% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $7.57 | +18.89% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $285.27 | +36.71% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $305.12 | -18.07% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $58.27 | +35.58% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $392.68 | +46.43% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $226.71 | -20.60% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $6.36 | +1,032.08% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $34.29 | -67.92% | 4 | May 4, 2021 |
Accendra Health
May 12, 2026
Maintains: Neutral
Price Target: $3 → $4.5
Current: $2.91
Upside: +54.64%
McKesson
May 8, 2026
Maintains: Buy
Price Target: $1,000 → $1,050
Current: $760.57
Upside: +38.05%
DENTSPLY SIRONA
May 7, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $10.07
Upside: +68.82%
Cencora
May 7, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $257.71
Upside: +59.87%
CVS Health
May 7, 2026
Maintains: Buy
Price Target: $97 → $100
Current: $95.89
Upside: +4.29%
Solventum
May 6, 2026
Maintains: Neutral
Price Target: $82 → $78
Current: $74.26
Upside: +5.04%
Henry Schein
May 6, 2026
Maintains: Neutral
Price Target: $87 → $85
Current: $72.72
Upside: +16.89%
AdaptHealth
May 6, 2026
Maintains: Buy
Price Target: $15 → $14
Current: $10.66
Upside: +31.33%
Quest Diagnostics
Apr 22, 2026
Maintains: Neutral
Price Target: $210 → $220
Current: $186.61
Upside: +17.89%
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $3.96
Upside: +26.26%
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $36.19
Upside: +57.50%
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $7.65
Upside: +56.86%
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $157.25
Upside: +17.65%
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $23.22
Upside: +7.67%
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $15.73
Upside: +33.50%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.43
Upside: +64.61%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $195.20
Upside: +12.70%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $393.85
Upside: +9.18%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $250.40
Upside: +27.80%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $184.99
Upside: -8.10%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $7.57
Upside: +18.89%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $285.27
Upside: +36.71%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $305.12
Upside: -18.07%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $58.27
Upside: +35.58%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $392.68
Upside: +46.43%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $226.71
Upside: -20.60%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $6.36
Upside: +1,032.08%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $34.29
Upside: -67.92%